The Global Amebiasis Treatment Market is predicted to increase significantly in Africa over the forecast period

Amebiasis Treatment Market Drivers

Increased approvals and releases of novel medications for the treatment of amebiasis are projected to drive the amebiasis treatment market forward. For example, the U.S. Food and Drug Administration (FDA) approved Dr. Reddy's Laboratories' Minolira (minocycline) extended-release tablets in 2017, which are used to treat a variety of bacterial infections and as supplementary therapy in acute intestinal amebiasis.Furthermore, in 2016, Aceto Corporation's Rising Pharmaceuticals, Inc. developed Metronidazole Tablets, 250mg and 500mg, a generic version of G.D. Searle, LLC's Flagyl, approved for the treatment of amebiasis and a variety of anaerobic bacterial infections. Doryx (Doxycycline Hyclate) Delayed-Release Tablets, 50 mg, manufactured by Mylan Pharmaceuticals Inc., got ANDA approval in 2016 for the treatment of acute intestinal amebiasis.


Furthermore, rising prevalence of amebiasis in areas with poor sanitation, such as Africa and some countries in Asia Pacific, is likely to fuel demand for amebiasis treatment in the near future, which would drive growth of the amebiasis treatment market. According to the International Research Journal of Biological Sciences, the prevalence of amebiasis among school pupils in Lafia, Nigeria, was around 26.7 percent in 2013. The children of Government Secondary School Tudun Kauri, Lafia, had the highest prevalence of amebiasis at 40.0 percent. The high frequency of amebiasis was caused by a poor environmental/drainage system, unsanitary sewage disposal methods, and a lack of clean water.

Amebiasis Treatment Market Regional Analysis

The global amebiasis treatment market is predicted to increase significantly in Africa over the forecast period, owing to a high prevalence rate of amebiasis caused by inadequate sanitation and a lack of safe drinking water. According to figures published by the United Nations Department of Economic and Social Affairs (UNDESA), around 115 people died every hour in Africa in 2014 due to diseases caused by poor sanitation, hygiene, and contaminated water.Approximately 40% of the 783 million people in Sub-Saharan Africa do not have access to safe drinking water. Furthermore, due to rising prevalence of amebiasis in some rural parts of India and China, the Asia Pacific region is likely to see considerable growth in the amebiasis treatment market throughout the forecast period. Amebiasis, for example, impacted nearly 15% of India's total population in 2015, according to data published on the National Health Portal of India.

Amebiasis Treatment Market Restraint

Amebiasis is a parasitic infection that thrives in regions with inadequate sanitation and a lack of safe drinking water. Because of the scarcity of hospitals and healthcare specialists in rural areas, residents have limited access to pharmaceuticals. The lack of adequate healthcare facilities and limited access to pharmaceuticals is likely to be a major stumbling block to the amebiasis treatment market's expansion.

Amebiasis Treatment Market Key Players

Pfizer Inc., Impax Laboratories, Lupin Pharmaceuticals, Inc., Sanofi, Actelion Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Inc., Heritage Pharmaceuticals Inc., Mission Pharmacal Co., Novel Laboratories, and others are among the major players in the amebiasis treatment market. The market's major players are concentrating on the launch of generic versions of branded drugs used to treat amebiasis. Mayne Pharma Group Limited, for example, got FDA approval for its Doxycyline Hyclate IR Tablets, the first generic to Acticlate, in 2017. Tetracycline class medications Doxycycline Hyclate 75 mg and 150 mg are indicated for supplementary therapy for acute intestinal amebiasis.

Comments

Post a Comment

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

Image
CGM (Continuous Glucose Monitoring) technology allows you to monitor your glucose levels 24 hours a day using a sensor that delivers the data to a MiniMed insulin pump. However, these devices also aid in diabetes management by lowering individual insulin dosages. These gadgets' integrated software provides users with information about food consumption, medication, physical activity, and ailments.  As a result, an increasing number of diabetic patients are relying on these devices to control and treat their condition, propelling market growth. A growing number of continuous glucose monitoring devices are being integrated with apps and software to treat people with diabetes mellitus, thanks to the development of digital medicines.The rising prevalence of diabetes mellitus has boosted the market for continuous glucose monitoring (CGM) devices. The Continuous Glucose Monitoring (CGM) Market is estimated to develop at a CAGR of 14% over the forecast period. High blood glucose levels oc...
Read more

YOU YES YOU!

Image
Welcome to Riya's  blog! HEY Everyone! So this is my my very first blog and  i am quite excited about it. WELL  I am  a 21 years old girl who sees the world through her eyes just like everyone else. I believe each of us have their own views and opinions about every little thing that we see through our eyes wide open and that is  what individuality is ! Having our own brains , hobbies,rights,skills , gifts ,flaws and i certainly believe that embracing them is one of the best things a human could do. Okay well so the topic on what  i am going to throw a little  light on here is not self love or self respect or being righteous , strong or anything like that , My topic here is going to be "YOU"   . "YOU" can be anyone here including me 'YOU' = "Individual" Isn't it so weird that in a world having  millions and millions of people  with their own "IDENTITIES " still lack " INDIVIDUALITY ". You know why? because...
Read more

Key Benefits of Breath Analyzer Market

Image
The Breath Analyzer is a gadget that uses a breath sample to determine an individual's Blood Alcohol Content (BAC). The test is based on the link between the amount of alcohol in the blood and the amount of alcohol in the breath going through the lungs. The use of breath analyzer equipment has increased as the trend for severe alcohol intake has increased, resulting in traffic accidents.  Government actions that favor the market are also propelling it forward. Breathalyzer devices are also gaining popularity as a result of the growing demand for accurate BAC (blood alcohol content) levels at work, as well as their non-invasive nature, which is driving up demand for breath analyzer equipment. It's a must-have tool for keeping track of drugs, alcohol, TB, and asthma. and other diseases hence; it is projected that the demand for this system should constantly rise.  Inaccurate analysis, on the other hand, might lead to wrong diagnosis, which is the market's main constrai...
Read more